Katerina Cizkova

Dr. Katerina Cizkova

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2011 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
AKAnna Konieczna
Anna Konieczna
BEB. Erdösová
B. Erdösová
RLR. Lichnovská
R. Lichnovská
MJM. Jandl
M. Jandl
KCKaterina Cizkova
Katerina Cizkova
JEJ. Ehrmann
J. Ehrmann

21 October 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
KCKaterina Cizkova
Katerina Cizkova
AKAnna Konieczna
Anna Konieczna
BEBela Erdosova
Bela Erdosova
RLRadka Lichnovska
Radka Lichnovska
JEJiri Ehrmann
Jiri Ehrmann
Embryonic and tumour cells are able to protect themselves against various harmful compounds. In human pathology, this phenomenon exists in the form of multidrug resistance (MDR) that significantly deteriorates success of anticancer treatment. Cytochromes P450 (CYPs) play one of the key roles in the xenobiotic metabolism. CYP expression could contribute to resistance of cancer cells to chemotherapy. CYP epoxygenases (CYP2C and CYP2J) metabolize about 20% of clinically important drugs. Besides of drug metabolism, CYP epoxygenases and their metabolites play important role in embryos, normal body function, and tumors. They participate in angiogenesis, mitogenesis, and cell signaling. It was found that CYP epoxygenases are affected by peroxisome proliferator-activated receptorα(PPARα). Based on the results of current studies, we assume that PPARs ligands may regulate CYP2C and CYP2J and in some extent they may contribute to overcoming of MDR in patients with different types of tumours.

13 March 2017 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
NANikola Ambrožová
Nikola Ambrožová
BZBohumil Zálešák
Bohumil Zálešák
JUJitka Ulrichová
Jitka Ulrichová
KCKaterina Cizkova
Katerina Cizkova
AGAdéla Galandáková
Adéla Galandáková

24 December 2018 in European Journal of Dental Education
Verified
Journal Article
Closed access
PDF file
ZTZdenek Tauber
Zdenek Tauber
KCKaterina Cizkova
Katerina Cizkova
RLRadka Lichnovska
Radka Lichnovska
HLHelena Lacey
Helena Lacey
BEBela Erdosova
Bela Erdosova
VKVojtech Kamarad
Vojtech Kamarad


26 November 2013 in Organogenesis
Verified
Journal Article
Closed access
KCKaterina Cizkova
Katerina Cizkova
AKAnna Konieczna
Anna Konieczna
BEBela Erdosova
Bela Erdosova
JEJiri Ehrmann
Jiri Ehrmann
There is growing evidence that some members of cytochrome P450 enzymes contribute to regulation of normal prenatal development. CYP epoxygenases (CYP2C and CYP2J subfamilies) convert arachidonic acid into four regioisomeric epoxyeicosatrienoic acids (EETs), biologically active molecules involved in mitogenesis and cell signaling. Almost nothing is known about localization of their expression in tissues during human prenatal development. The spatio-temporal expression pattern of CYP2C8, CYP2C9, CYP2C19 and CYP2J2 in human embryonic/fetal intestines, liver, and kidney was investigated by immunohistochemical method. CYP epoxygenases are expressed already in early stages of development in these embryonic/fetal tissues (as early as 7th week of IUD in the intestines, 5th week of IUD in the liver, and 6th week of IUD in the kidney). In kidney, CYP epoxygenases are expressed in the metanephrogenic blastema (but not in the uninduced mesenchyme) and in the tubular system. In the intestines, diverse CYP epoxygenases distribution along crypt-villus axis could suggest role in cell differentiation. Moreover, we detected higher CYP2J2 level in these organs than in adult tissue samples.